Gene expression profile of Li23, a new human hepatoma cell line that enables robust hepatitis C virus replication: Comparison with HuH-7 and other hepatic cell lines

Hepatology Research

Volumn 40, Issue 12, 2010, Pages 1248-1253

  Mori, Kyoko ^a   Ikeda, Masanori ^a   Ariumi, Yasuo ^a   Kato, Nobuyuki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Hepatitis C virus; Hepatoma cell line; HuH 7; Li23; Microarray

Indexed keywords

ARTICLE; CELL LINE; CELL LINE HUH 7; CELL LINE LI23; COMPARATIVE STUDY; DNA MICROARRAY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS REPLICATION;

EID: 78649872069     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2010.00730.x     Document Type: Article

References (21)

1. Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 1982; 42: 3858-63.
2. Lohmann V, Körner F, Koch J-O, Herian U, Theilman L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999; 285: 110-13.
3. Wakita T, Pietschmann T, Kato T et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005; 11: 791-6.
4. Kato N, Sugiyama K, Namba K et al. Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro. Biochem Biophys Res Commun 2003; 306: 756-66.
5. Ikeda M, Abe K, Dansako H, Nakamura T, Naka K, Kato N. Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system. Biochem Biophys Res Commun 2005; 329: 1350-9.
6. Ariumi Y, Kuroki M, Abe K et al. DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication. J Virol 2007; 81: 13922-6.
7. Kato N, Mori K, Abe K et al. Efficient replication systems for hepatitis C virus using a new human hepatoma cell line. Virus Res 2009; 146: 41-50.
8. Tokiwa T, Doi I, Sato J. Preparation of single cell suspensions from hepatoma cells in culture. Acta Med Okayama 1975; 29: 147-50.
9. Aden DP, Fogel A, Plotkin S, Damjanov I, Knowles BB. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 1979; 282: 615-16.
10. Doi I, Nambe M, Sato J. Establishment and some biological characteristics of human hepatoma cell lines. Gann 1975; 66: 385-92.
11. Alexander JJ, Bey EM, Geddes EW, Lecatsaa G. Establishment of a continuously growing cell line from primary carcinoma of the liver. S Afr Med J 1976; 50: 2124-8.
12. Ikeda M, Sugiyama K, Mizutani T et al. Human hepatocyte clonal cell lines that support persistent replication of hepatitis C virus. Virus Res 1998; 56: 157-67.
13. Dansako H, Naganuma A, Nakamura T, Ikeda F, Nozaki A, Kato N. Differential activation of interferon-inducible genes by hepatitis C virus core protein mediated by the interferon stimulated response element. Virus Res 2003; 97: 17-30.
14. Yoshida N, Abe H, Ohkuri T et al. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance. Int J Oncol 2006; 28: 1089-98.
15. Caballero OL, Chen YT. Cancer/testis (CT) antigens: potential targets for immunotherapy. Cancer Sci 2009; 100: 2014-21.
16. Korangy F, Ormandy LA, Bleck JS et al. Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma. Clin Cancer Res 2004; 10: 4332-41.
17. Bensch KW, Raida M, Magert HJ, Schulz-Knappe P, Forssmann WG. HBD-1: a novel bta-defensin from human plasma. FEBS Lett 1995; 368: 331-5.
18. Droin N, Hendra JB, Ducoroy P, Solary E. Human defensins as cancer biomarkers and antitumour molecules. J Proteomics 2009; 72: 918-27.
19. Dumic J, Dabelic S, Flögel M. Galectin-3: an open-ended story. Biochim Biophys Acta 2006; 1760: 616-35.
20. Danguy A, Camby I, Kiss R. Galectins and cancer. Biochim Biophys Acta 2002; 1572: 285-93.
21. Hsu DK, Dowling CA, Jeng KC, Chen JT, Yang RY, Liu FT. Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma. Int J Cancer 1999; 81: 519-26.